BCL6 is required for the thymic development of TCRαβ+CD8αα+ intraepithelial lymphocyte lineage

Sci Immunol. 2024 Sep 2;9(92):eadk4348. doi: 10.1126/sciimmunol.adk4348. Epub 2024 Feb 9.

Abstract

TCRαβ+CD8αα+ intraepithelial lymphocytes (CD8αα+ αβ IELs) are a specialized subset of T cells in the gut epithelium that develop from thymic agonist selected IEL precursors (IELps). The molecular mechanisms underlying the selection and differentiation of this T cell type in the thymus are largely unknown. Here, we found that Bcl6 deficiency in αβ T cells resulted in the near absence of CD8αα+ αβ IELs. BCL6 was expressed by approximately 50% of CD8αα+ αβ IELs and by the majority of thymic PD1+ IELps after agonist selection. Bcl6 deficiency blocked early IELp generation in the thymus, and its expression in IELps was induced by thymic TCR signaling in an ERK-dependent manner. As a result of Bcl6 deficiency, the precursors of IELps among CD4+CD8+ double-positive thymocytes exhibited increased apoptosis during agonist selection and impaired IELp differentiation and maturation. Together, our results elucidate BCL6 as a crucial transcription factor during the thymic development of CD8αα+ αβ IELs.

MeSH terms

  • Animals
  • CD8 Antigens / metabolism
  • CD8-Positive T-Lymphocytes / metabolism
  • Intestinal Mucosa
  • Intraepithelial Lymphocytes* / metabolism
  • Mice
  • Mice, Knockout
  • Proto-Oncogene Proteins c-bcl-6* / metabolism
  • Receptors, Antigen, T-Cell, alpha-beta* / genetics
  • Receptors, Antigen, T-Cell, alpha-beta* / metabolism

Substances

  • CD8 Antigens
  • Receptors, Antigen, T-Cell, alpha-beta
  • Bcl6 protein, mouse
  • Proto-Oncogene Proteins c-bcl-6